Category:
Cardiovascular System Drugs
CAS NO:
220127-57-1
Standard:
ChP,
Treatment of leukemia
Imatinib mesylate (CAS: 152459-05-7) is a targeted therapy agent defined by its tyrosine kinase inhibitor mechanism. Synthesized via condensation reactions, its molecular formula is C15H16N5O·CH3SO3H.
Strictly contraindicated for severe hepatic impairment. Store below 25°C in moisture-proof containers. Handle with PPE to prevent dermal absorption during manufacturing.